2,3,4,5-tetrahydroxypentanal has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, T | 1 |
| Liu, DD | 1 |
| Ning, HM | 1 |
| Sun, JY | 1 |
| Huang, XJ | 1 |
| Dong, Y | 1 |
| Geng, MY | 1 |
| Yun, SF | 1 |
| Yan, J | 1 |
| Huang, RM | 1 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Bladder Cancer
| Article | Year |
|---|---|
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood Proteins; Caspase 3; Cell Line, Tumor; Down-Regulat | 2018 |